Rheumatoid arthritis drugs for schizophrenia?

Peter F. Buckley, Brian J. Miller

Research output: Contribution to journalArticlepeer-review


Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheu-matic drugs—from various nonsteroidal anti-inflammatory drugs to more selective anticytokine monoclonal antibodies—in patients with schizophrenia. The results and focus of this work are detailed in this article.

Original languageEnglish (US)
Pages (from-to)232-236
Number of pages5
JournalPsychiatric Annals
Issue number5
StatePublished - May 2018

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Rheumatoid arthritis drugs for schizophrenia?'. Together they form a unique fingerprint.

Cite this